In the Boardroom
Refine Search
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO). 9 October 2024
Biotechnology
Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including seed financing and Series A. 7 October 2024
Biotechnology
Mosaic Therapeutics, a UK-based oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, has announced the appointment of Barry Davies as chief scientific officer. 7 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Biotechnology
Privately-held Akrevia Therapeutics today announced that Joseph Farmer has been appointed as chief operating officer of the biopharma company launched by Atlas Ventures and F-Prime last September. 13 June 2019
Biotechnology
California-based rare diseases specialist Eiger BioPharmaceuticals today announced the appointment of Mark Mannebach, as vice president of global regulatory affairs. 10 June 2019
Pharmaceutical
UK developer of inhaled therapeutics Vectura today announces that James Ward-Lilley will be stepping down from the Board and his position as chief executive on June 30, 2019. 10 June 2019
Pharmaceutical
In a surprise announcement, French pharma major Sanofi has revealed that chief executive Olivier Brandicourt will retire in September, to be replaced by Novartis’ current pharma chief, Paul Hudson. 7 June 2019
Pharmaceutical
Pfizer has announced that Jeff Settleman has joined the company as senior vice president and group head of Oncology Research and Development. 6 June 2019
Biotechnology
After 20 years in various leadership roles with US pharma major Eli Lilly, Pete Salzmann has left to take the top job at a company specializing in autoimmune diseases. 6 June 2019
Pharmaceutical
Bristol-Myers Squibb has outlined the executive team that will take the newly-enlarged firm forward after its acquisition of rival oncology specialist Celgene. 5 June 2019
Biotechnology
California-based rare diseases specialist Eiger BioPharmaceuticals today announced the appointment of Jeysen Yogaratnam as vice president of global hepatitis Delta virus (HDV) clinical development. 5 June 2019
Pharmaceutical
Privately-held Danish medical dermatology specialist LEO Pharma today announced that Gitte Aabo will step down as president and chief executive after 27 years in the company, 11 of which were as CEO. 4 June 2019
Biotechnology
Germany’s Ethris, a leader in mRNA-based therapeutics, is expanding its leadership team by the addition of Thomas Langenickel in the role of chief medical officer. 4 June 2019
Pharmaceutical
Jazz Pharmaceuticals today announced the appointment of Dr Robert Iannone as executive vice president, research and development, effective May 29, 2019. 3 June 2019
Pharmaceutical
Regulatory decisions last week including good news for Novartis and not so good for Newron Pharmaceuticals. For the Swiss pharma giant, the US Food and Drug Administration granted approval for its spinal muscular atrophy drug Zolgensma (SMA), but it also comes with a hefty price tag of over $2 million. Italy’s Newron had a set back with the FDA delaying studies of its schizophrenia candidate evenamide. On the price front, the UK’s cost-effectiveness body the National Institute for Health and Care Excellence (NICE) gave its backing for Merck & Co’s Prevymis for the treatment on cytomegalovirus. Executive shuffles last week included Gilead Sciences naming a new chief commercial officer, nabbing a Bristol-Myers Squibb exec for the role. 2 June 2019
Biotechnology
Atara Biotherapeutics, a US biotech specializing in T-cell immunotherapies for cancer, has named Pascal Touchon its new president, chief executive. 30 May 2019
Pharmaceutical
The US subsidiary of Japanese drug major Eisai yesterday announced the immediate appointment of Adriana Herrera as senior vice president, Americas Commercial Oncology. 30 May 2019
Biotechnology
US biotech major Gilead Sciencestoday announced that Johanna Mercier will join the company as chief commercial officer, and will become a member of the company’s senior leadership team. 29 May 2019
Biotechnology
Cambridge, Massachusetts-based genome editing company Intellia Therapeutics has named Laura Sepp-Lorenzino as its new executive vice president and chief scientific officer. 28 May 2019
Biotechnology
Akrevia Therapeutics, a privately-held biopharma that was launched in September 2018 by Atlas and F-Prime, has now named its first chief executive. 23 May 2019
Biotechnology
Oncology heavyweight Robin Taylor has made the switch from VP level at big pharma to chief commercial officer at an emerging, multi-product biotech company. 23 May 2019
Pharmaceutical
The US subsidiary of Japanese drugmaker Eisai has appointed Dr Luca Dezzani as vice president, US medical affairs, Oncology Business Group. 20 May 2019
Pharmaceutical
UK and USA-based specialty drugmaker EUSA Pharma today announced the strengthening of its senior leadership team with the appointments of Carsten Thiel as president Europe and Darrel Cohen as head of clinical development. 15 May 2019
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze